Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $115

Morgan Stanley analyst Vikram Purohit maintains $Axsome Therapeutics(AXSM.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 2

Futu NewsJun 22 22:32 · Ratings

ResMed, Philips Under Pressure as Eli Lilly Seeks Sleep Indication for Weight Loss Drug

Seeking AlphaJun 22 20:27

Investors Ignore Increasing Losses at Axsome Therapeutics (NASDAQ:AXSM) as Stock Jumps 7.0% This Past Week

Yahoo FinanceJun 19 20:23

Citi's North America Focus List Updated, Adds: Coca-Cola, Evergy, Etc.

Seeking AlphaJun 13 23:02

A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $106 to $125

On Jun 12, major Wall Street analysts update their ratings for $Axsome Therapeutics(AXSM.US)$, with price targets ranging from $106 to $125.Morgan Stanley analyst Vikram Purohit maintains with a buy r

Futu NewsJun 12 21:00 · Ratings

Investors Push Axsome Therapeutics (NASDAQ:AXSM) 4.1% Lower This Week, Company's Increasing Losses Might Be to Blame

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well o

Simply Wall StJun 12 20:12